EcoDrugPlus

Adrenoceptor Alpha 2b

Ensembl ID : ENSACIG00000008037
Gene Symbol: ADRA2B
1 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSACIG00000005900
Gene Symbol: ADRA2B
1 Cross references
175 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSACIG00000013990
Gene Symbol: ADRA2C
2 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSACIG00000006076
Gene Symbol: ADRA2C
1 Cross references
162 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSACIG00000010487
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSACIG00000020563
Gene Symbol: ADRB2
1 Cross references
168 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSACIG00000015862
Gene Symbol: ADRB2A
1 Cross references
196 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSACIG00000006513
Gene Symbol: ADRB3A
1 Cross references
197 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSACIG00000019289
Gene Symbol: AKR1B1.1
1 Cross references
350 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSACIG00000019277
Gene Symbol: AKR1B1.2
1 Cross references
348 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSACIG00000021509
Gene Symbol: GAA
2 Cross references
232 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSACIG00000015950
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).